Birman, Einladung voll

Evolving Cochlear Implant Indications — PORA Webinar with Prof. Catherine Birman
PORA 2026 Webinar Invitation Friday, 27 November 2026 · 15:00 CET

Evolving Cochlear Implant Indications: How Outcomes Drive Candidacy and Governance

An international clinical briefing with Clinical Professor Catherine S. Birman OAM MBBS PhD FRACS (Sydney University, Australia), examining how longitudinal outcomes reshape candidacy criteria, test-battery counselling, and surgical governance.

Live Session Date
27 Nov 2026
8 days remaining
Scheduled Broadcast
15:00 CET
Amsterdam · Berlin · Rome
Clinical Experience
25+ Years
Pediatric & adult hearing loss
Surgical Volume
2,100+
Cochlear implants in Sydney
01 · Clinical Premise

Candidacy Is an Evolving Process, Not a Static Threshold

Cochlear implant candidacy has never stood still. As surgical techniques, electrode designs, and rehabilitation outcomes improve, the thresholds that define who benefits from implantation expand in both the short and long term.

In this PORA 2026 session, Clinical Professor Catherine Birman reframes cochlear implant indications around outcome-driven evidence — drawing on Australia’s evolving clinical environment as a lens for what otology and audiology programs elsewhere may soon encounter, and detailing the governance frameworks required to protect long-term results.

Interactive Session Framework — Select a Pillar
01 · CRITERIA Indications Over Time 02 · EVALUATION Test Batteries 03 · OVERSIGHT Surgical Governance Click any node to inspect how the webinar links clinical outcomes to governance.

Contrasting Historical & Modern Indications

Examines why surgical indications exist and how candidacy evaluation has shifted over both short- and long-term horizons in response to observed clinical outcomes.

  • How candidacy boundaries evolved in the Australian clinical environment
  • Short-term vs. long-term factors shaping individual recommendations
  • Why clear indication criteria remain essential as access broadens
02 · Webinar Objectives

Five Questions Addressed in This Briefing

  1. 01 Contrast cochlear implant candidacy evaluation indications and trace how those criteria have changed over time. Evaluation
  2. 02 Reframe cochlear implant indications as an evolving process across both the short and long term, identifying the factors that influence clinical recommendations. Process
  3. 03 Examine why formal indications exist for cochlear implant surgery and what clinical purpose they serve. Rationale
  4. 04 Consider practical designs for governance in cochlear implant surgery aimed at optimising long-term patient outcomes. Design
  5. 05 Evaluate governance factors tied directly to sustained cochlear implant outcomes and lifelong post-operative support. Long-Term Care
03 · Key Highlights

What Participants Will Learn

Highlight 01 · Comparative Context

Australia’s Evolving CI Landscape

See how cochlear implant indications have changed — and continue to shift — in the Australian environment, offering a preview of transitions likely to occur in your own clinical setting.

Highlight 02 · Clinical Oversight

The Case for Surgical Governance

Understand why formal governance structures are indispensable as candidacy broadens, aligning institutional accountability with consistent patient outcomes.

Highlight 03 · Patient Counselling

Applying Test Batteries to Expectations

Learn how clinicians interpret candidacy test batteries and translate those findings into transparent, evidence-based counselling on expected post-implant outcomes.

Highlight 04 · Continuity

Governance for Long-Term Support

Identify the governance factors that protect outcomes beyond surgery, ensuring patients receive structured follow-up and long-term device support.

04 · Keynote Speaker

Clinical Professor Catherine S. Birman

Clinical Professor Catherine S. Birman OAM MBBS PhD FRACS

Ear, Nose & Throat Surgeon · Sydney University, Australia

Clinical Professor Catherine Birman is an Ear, Nose and Throat Surgeon with more than 25 years’ experience treating pediatric and adult hearing loss, having performed over 2,100 cochlear implants in Sydney, Australia. She presents nationally and internationally and has published extensively across otolaryngology and hearing restoration.

As a leading ENT surgeon and researcher, Professor Birman pioneers clinical trials spanning novel cochlear implant devices and inaugural gene therapy studies for hearing loss. Her career encompasses senior leadership roles across major Sydney hospitals, Sydney University, and international advocacy boards, earning prestigious recognition including the Order of Australia Medal (OAM).

Dimension Profile Detail Benchmark
Qualifications & Honour MBBS, PhD, FRACS; Order of Australia Medal OAM
Clinical Practice Pediatric and adult hearing loss management in Sydney, Australia 25+ Years
Surgical Experience Cochlear implantation procedures performed 2,100+ Implants
Research & Trials Novel cochlear implant devices & inaugural gene therapy studies for hearing loss Lead Investigator
Institutional Leadership Major Sydney hospitals, Sydney University, and international advocacy boards Sydney & Global

Leave a Comment - join the PORA Community of Practice (CoP)

This site uses Akismet to reduce spam. Learn how your comment data is processed.